ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Bit Digital (BTBT) missed Q3 2025 earnings estimates, reporting a larger-than-expected loss. The stock fell sharply in pre-market trading following the disappointing results.
ASML stock combines strong fundamentals with a bullish technical breakout setup. High profitability, solid growth, and a positive market trend make it a compelling growth stock.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
QFIN Holdings is a top Peter Lynch GARP stock with 20% EPS growth, a low 0.16 PEG ratio, and strong financial health. This Chinese fintech offers sustainable growth at a reasonable price.
Spire Inc (SR) missed Q4 2025 revenue and EPS estimates, leading to a negative pre-market stock reaction. The report contrasts with the company's full-year net income.
Newmont Corp (NEM) presents a compelling value investment case with strong valuation metrics, high profitability, and a solid financial health profile.
Align Technology (ALGN) appears undervalued with a low P/E ratio, zero debt, strong profitability, and solid growth potential, fitting classic value investing principles.
The Trade Desk exemplifies the Caviar Cruise strategy with exceptional growth, 25% ROIC, strong cash flow, and zero debt. A top-tier quality growth stock.
Discover how Arista Networks (ANET) exemplifies the CANSLIM investing method with strong earnings growth, high profitability, and solid market momentum.
Universal Technical Institute (UTI) offers strong growth, solid profitability, and a reasonable valuation, positioning it as a leader in skilled trades and healthcare education.
A.O. Smith Corp. (AOS) is a top dividend stock with a 10+ year payment history, a sustainable payout ratio, and strong financial health for reliable income.
Market breadth deteriorated significantly on Thursday, November 13. Advancing issues collapsed while decliners surged, undoing most of the prior day’s gains. This sharp reversal raises concerns about the sustainability of recent strength and places the current breadth trend firmly back in negative territory.
CROX stock appears deeply undervalued with a low P/E ratio, strong profitability, and solid financial health, making it a compelling value investing opportunity.
Power Solutions International (PSIX) is a fundamentally strong, undervalued stock with exceptional profitability and a healthy balance sheet, presenting a compelling value investment opportunity.
Wall Street reversed course Thursday, led by a sharp selloff in tech stocks as doubts grow over a December rate cut. AI high-flyers like Palantir and Nvidia tumbled, while Cisco stood out with strong results and raised guidance.
Globant's Q3 2025 results show a revenue beat but an earnings miss, causing a 4% stock drop. The company continues its strategic focus on AI-driven digital transformation.
GrabAGun's Q3 results show a strong revenue beat but a surprise earnings miss. The stock fell as investors focused on the quarterly loss despite solid sales growth and a strong cash position.
Beazer Homes Q4 earnings crush estimates with a 17.4% revenue beat and 33.8% EPS beat, driving shares up 8% as the homebuilder outperforms in a tough market.
RenovoRx Q3 2025 earnings show a 35% revenue miss, causing a stock drop. The clinical-stage biopharma provided a 2026 growth outlook to offset cash burn.
Marchex reports Q3 2025 results, missing revenue but meeting profit targets. The stock rose on news of its strategic Archenia acquisition and a positive 2026 growth outlook.
The Glimpse Group (VRAR) Q1 FY2026 revenue missed estimates, but its EPS loss was slightly better than expected. The company is focused on its Brightline Interactive spinoff and new government contracts.
AirJoule (AIRJ) stock rose after Q3 2025 results, beating EPS estimates with a smaller loss. The water-harvesting tech firm also announced key partnerships and progress toward 2026 commercialization.
Applied Materials (AMAT) narrowly beat Q4 FY2025 earnings and revenue estimates, achieving record annual results driven by AI and advanced semiconductor demand.
Trevi Therapeutics reported a narrower-than-expected Q3 2025 loss. The biopharma firm is preparing its Phase 3 program for Haduvio and has cash into 2028.
Precigen's Q3 2025 results show a huge revenue beat but a wider-than-expected loss. The key highlight is the full FDA approval and launch of its new therapy, PAPZIMEOS.
Hyperfine (HYPR) reported mixed Q3 2025 results, missing revenue and EPS estimates. The stock fell as its Q4 revenue guidance also trailed analyst expectations.
Net Power stock fell 12% after a strategic pivot to carbon capture tech, overshadowing an accounting-driven EPS beat and revealing a major asset impairment.
HeartBeam reports Q3 2025 results, missing EPS estimates. The pre-revenue firm focuses on FDA clearance for its cardiac tech, a key milestone expected by year-end.
BioAtla (BCAB) beat Q3 2025 EPS estimates, sending its stock up 7.5%. The biotech also gained FDA alignment for its Phase 3 trial in head and neck cancer.
TELA Bio reports Q3 2025 results with 9% revenue growth to $20.7M, missing estimates. The company improved its net loss and secured new financing for future expansion.
Rekor Systems (REKR) smashed Q3 2025 estimates with record revenue of $14.2M and a smaller-than-expected loss, sparking a positive after-hours market reaction.
WidePoint's Q3 2025 earnings show a revenue miss but strong sequential profit growth. The company secured major new contracts and maintains a $269M backlog for future growth.
Cytosorbents Q3 2025 earnings show a mixed quarter, beating EPS estimates but missing on revenue. The stock saw volatility despite a strengthened balance sheet.
Evolv Technology (EVLV) crushed Q3 2025 earnings estimates, reporting a surprise profit and strong revenue growth. The company also raised its full-year guidance.
